ELV - Company ID 0001156039
Elevance Health, Inc. (ELV) reported revenue of $199.13B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $199.13B | +12.5% |
| FY 2024 | $177.01B | +3.3% |
| FY 2023 | $171.34B | +9.4% |
| FY 2022 | $156.59B | +13.0% |
| FY 2021 | $138.64B | +13.8% |
| FY 2020 | $121.87B | +16.9% |
| FY 2019 | $104.21B | +13.1% |
| FY 2018 | $92.11B | +2.3% |
| FY 2017 |
Elevance Health, Inc. (ELV) reported revenue of $199.13B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Elevance Health, Inc.'s revenue grew from $60.71B to $199.13B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $90.04B |
| +6.1% |
| FY 2016 | $84.86B | +7.2% |
| FY 2015 | $79.16B | +7.2% |
| FY 2014 | $73.87B | +4.0% |
| FY 2013 | $71.02B | +15.5% |
| FY 2012 | $61.50B | +1.3% |
| FY 2011 | $60.71B | - |